Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] stock went on an upward path that rose over 0.54% on Thursday, amounting to a one-week price increase of more than 1.82%.
Over the last 12 months, RVPH stock dropped by -78.34%. The one-year Reviva Pharmaceuticals Holdings Inc stock forecast points to a potential upside of 94.62. The average equity rating for RVPH stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $26.65 million, with 68.00 million shares outstanding and 60.81 million shares in the current float. Compared to the average trading volume of 1.35M shares, RVPH stock reached a trading volume of 6131365 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Reviva Pharmaceuticals Holdings Inc [RVPH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RVPH shares is $7.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RVPH stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH MKM have made an estimate for Reviva Pharmaceuticals Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 20, 2023. While these analysts kept the previous recommendation, The Benchmark Company raised their target price to Speculative Buy. The new note on the price target was released on June 08, 2023, representing the official price target for Reviva Pharmaceuticals Holdings Inc stock. Previously, the target price had yet another raise to $10, while H.C. Wainwright analysts kept a Buy rating on RVPH stock.
RVPH Stock Performance Analysis:
Reviva Pharmaceuticals Holdings Inc [RVPH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.82. With this latest performance, RVPH shares dropped by -53.61% in over the last four-week period, additionally sinking by -80.10% over the last 6 months – not to mention a drop of -78.34% in the past year of trading.
Insight into Reviva Pharmaceuticals Holdings Inc Fundamentals:
Return on Equity for this stock declined to -281.12%, with Return on Assets sitting at -281.12%.
RVPH Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RVPH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Reviva Pharmaceuticals Holdings Inc go to 22.43%.
Reviva Pharmaceuticals Holdings Inc [RVPH] Institutonal Ownership Details
There are presently around $20.35%, or 22.68% of RVPH stock, in the hands of institutional investors. The top three institutional holders of RVPH stocks are: WOODLINE PARTNERS LP with ownership of 1.59 million shares, which is approximately 5.2129%. MILLENNIUM MANAGEMENT LLC, holding 1.24 million shares of the stock with an approximate value of $$1.59 million in RVPH stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $$1.31 million in RVPH stock with ownership which is approximately 3.3554%.
